1.2.1.31 C125I mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 D126E mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 D94E mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 E173D mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 F93W mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 F95W mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 G124A mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 G79A mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 G848K enzyme activity not detectable 288187 1.2.1.31 G874ade/874R/874K lys arg double mutation in strain G874 isolated after a second induced mutagenesis in ade mutant G846 288187 1.2.1.31 G905K enzyme activity detectable 288187 1.2.1.31 G910A mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 G982K enzyme activity detectable 288187 1.2.1.31 G983ade/983K lys mutation in strain G983 isolated after a second induced mutagenesis in ade mutant G846, enzyme activity detectable 288187 1.2.1.31 G984K very low activity 288187 1.2.1.31 G985K enzyme activity not detectable 288187 1.2.1.31 K172R mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 K177R mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 additional information alpha-AASA dehydrogenase deficiency is characterised by increases of alpha-aminoadipic semialdehyde in urine, plasma and cerebrospinal fluid 694191 1.2.1.31 N96D mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 P81A mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 R80K mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 S913A mutant enzyme shows no alpha-aminoadipate reductase activity 657420 1.2.1.31 S913T mutant enzyme shows no alpha-aminoadipate reductase activity 657420